Fredrik Gilstring

Gustavia Fonder AB (Gustavia) is the fund management subsidiary of Gustavia Holding AB in Sweden. Created in 2010 when Gustavia Capital Management AB and Davegårdh & Kjäll Fonder AB merged, the firm offers a range of actively managed funds that serve as both basic and special investments. Gustavia is based in Stockholm and manages funds which invest in Sweden, the Balkans, the Middle East, Russia and emerging countries like China, India and Brazil.

Axelar AB operates as a biotechnology company. It aims to develop novel efficacious anti-cancer treatments. The company was founded by Erik Gustav Magnus Axelson and Lars Olov Larsson in 2003 and is headquartered in Solna, Sweden.